Skip to content

Meal Delivery and Exercise

A Meal Delivery and Exercise Intervention to Increase Resilience in Homebound Older Adults

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04906759
Enrollment
100
Registered
2021-05-28
Start date
2021-07-19
Completion date
2026-02-28
Last updated
2024-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty

Keywords

homebound patients, exercise, nutrition

Brief summary

The purpose of this study is to evaluate the effects of a home-based exercise program administered through Meals on wheels (MOW) on gait speed and frailty status and to assess the association between novel serum biomarkers (70 kilodalton heat shock proteins (HSP70),Macrophage Inflammatory Proteins(MIP1b), soluble IL-6 receptor alpha-chain (sIL-6R)) and established but non-specific frailty biomarkers (Interleukin 6 (IL-6), C-reactive protein (CRP), Tumor necrosis factor (TNF-α)) in frail and prefrail homebound older adults before and after the exercise intervention.

Interventions

Participants will receive 12 weeks of a MOW delivery service that will include 2 meals per day during the weekdays with 4 shelf-stable meals at the end of the week. The MOW driver will visit the participants in-person to ask a series of 5 questions about change in health status, joint/muscle injuries, new pain, falls, and poor appetite twice a week. Participants will also will receive an exercise kit from the MOW driver with their first meal delivery which will contain 2 tennis balls, 2 1-pound hand weights, and one towel. Every week, the driver will give the participants a handout containing 3 exercises from the NIA Go4Life Workout-to-Go book that are designed to help with strength/endurance, balance, and flexibility20. The participants will be asked to do the 3 exercises every day, if possible, on their own. Every 4 weeks during the 12-week study period and at 6 months follow up patients will have blood drawn for frailty and inflammatory biomarkers.

BEHAVIORALMeals only

Participants will receive 12 weeks of a MOW delivery service that will include 2 meals per day during the weekdays with 4 shelf-stable meals at the end of the week. The MOW driver will visit the participants in-person to ask a series of 5 questions about change in health status, joint/muscle injuries, new pain, falls, and poor appetite twice a week. they will be asked to continue their usual level of activity.Every 4 weeks during the 12-week study period and at 6 months follow up patients will have blood drawn for frailty and inflammatory biomarkers.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* homebound (normally unable to leave the home unassisted) * frail or prefrail by The Fried Frailty Phenotype (FFP) * medically stable

Exclusion criteria

* robust by FFP * have Mini-Cog score \<3 and/or are unable to follow instructions * have a pre-diagnosed terminal illness * unable to ambulate * unable to use their upper extremities, and/or are already participating in physician-prescribed physical therapy or occupational therapy.

Design outcomes

Primary

MeasureTime frameDescription
Change in gait speed4 weeks,8 weeks,12 weeks from baselinethis is the time one takes to walk a specified distance on level surfaces over a short distance and is measured in meters/second
Change in total FFP score as assessed by the Fried Frailty Phenotype (FFP) screening test4 weeks,8 weeks,12 weeks from baselineScore from 0(not frail),1-2(pre frail) and 3-5(frail)
Change in measure of HSP70 (ng/mL) expression4 weeks,8 weeks,12 weeks from baseline
Change in Measure of MIP-1β (pg/mL) expression4 weeks,8 weeks,12 weeks from baseline
Change in Measure of sIL-6R (pg/mL) expression4 weeks,8 weeks,12 weeks from baseline

Secondary

MeasureTime frameDescription
Change in activities of daily living as measured by the Katz Index of Independence in Activities of Daily Living4 weeks,8 weeks,12 weeks from baselineThis consists of 6 questions and each is scored form 0(patient is very dependent)-6(patient is independent)
Change in instrumental activities of daily living as measured by the LAWTON - BRODY INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE (I.A.D.L.)4 weeks,8 weeks,12 weeks from baselineThis consists of 8 questions and each has a summary score range from 0 (low function, dependent) to 8 (high function, independent) for women and 0 through 5 for men to avoid potential gender bias.
Change in loneliness as assessed by the UCLA Loneliness Scale (ULS)4 weeks,8 weeks,12 weeks from baselineThis questionnaire consists of 20 questions and each is answered from 1(never)-4(always) for a total score ranging form 20-80
Social network as assessed by the LUBBEN SOCIAL NETWORK SCALE - 18 (LSNS-18)4 weeks,8 weeks,12 weeks from baselineLSNS-R total score is an equally weighted sum of twelve items. Scores range from 0 to 90, a higher number indicating a better outcome
change in measure of IL-6 (pg/mL) expression4 weeks,8 weeks,12 weeks from baseline
Change in measures of CRP (ng/mL) expression4 weeks,8 weeks,12 weeks from baseline
Change in measures of TNF-α (pg/mL) expression4 weeks,8 weeks,12 weeks from baseline
Change in overall frailty status as assessed by the Fried Frailty Phenotype (FFP) screening test4 weeks,8 weeks,12 weeks from baselineThe FFP defines frailty as having 3 or more characteristics of unintentional weight loss, fatigue, decreased physical activity, weakness, and slowness.Those who have 1 or 2 characteristics are considered pre frail, while those who have no characteristics are robust.
change in IL-6 (pg/mL) as measured by the frailty status4 weeks,8 weeks,12 weeks from baseline
change in CRP (ng/mL) as measured by the frailty status4 weeks,8 weeks,12 weeks from baseline
change in TNF-α (pg/mL) as measured by the frailty status4 weeks,8 weeks,12 weeks from baseline
change in HSP70 (ng/mL) as measured by the frailty status4 weeks,8 weeks,12 weeks from baseline
change in MIP-1β (pg/mL) as measured by the frailty status4 weeks,8 weeks,12 weeks from baseline
change in sIL-6R (pg/mL) as measured by the frailty status4 weeks,8 weeks,12 weeks from baseline
change in microbiome (fecal sample) as measured by the frailty status4 weeks,8 weeks,12 weeks from baseline
Change in measures of microbiome (fecal sample) expression4 weeks,8 weeks,12 weeks from baseline
Change in grip strength4 weeks,8 weeks,12 weeks from baselineGrip strength is a measure of muscular strength or the maximum force/tension generated by one's forearm muscles .This is measured by using a dynamometer which will be squeezed by the participant 3 times in each hand.The force is measured in kilograms.
Change in daily average steps from the activity tracker4 weeks,8 weeks,12 weeks from baseline
Number of patients that required emergency room visits6 months post baseline visit
Number of patients that required hospitalization6 months post baseline visit

Countries

United States

Contacts

Primary ContactJessica Lee, MD,MS
Jessica.Lee@uth.tmc.edu713-500-5457
Backup ContactPaola Robles Cordova
Paola.RoblesCordova@uth.tmc.edu(713) 500-7904

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026